- Home
- PTGX vs BUR Comparison
PTGX vs BUR Comparison
Compare PTGX & BUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- BUR
- Stock Information
- Founded
- PTGX 2006
- BUR 2009
- Country
- PTGX United States
- BUR Guernsey
- Employees
- PTGX N/A
- BUR N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- BUR Finance: Consumer Services
- Sector
- PTGX Health Care
- BUR Finance
- Exchange
- PTGX Nasdaq
- BUR Nasdaq
- Market Cap
- PTGX 2.9B
- BUR 2.9B
- IPO Year
- PTGX 2016
- BUR 2010
- Fundamental
- Price
- PTGX $53.34
- BUR $11.00
- Analyst Decision
- PTGX Strong Buy
- BUR Strong Buy
- Analyst Count
- PTGX 9
- BUR 3
- Target Price
- PTGX $67.11
- BUR $18.00
- AVG Volume (30 Days)
- PTGX 898.5K
- BUR 1.7M
- Earning Date
- PTGX 08-05-2025
- BUR 08-07-2025
- Dividend Yield
- PTGX N/A
- BUR 1.13%
- EPS Growth
- PTGX N/A
- BUR N/A
- EPS
- PTGX 0.86
- BUR 0.93
- Revenue
- PTGX $207,801,000.00
- BUR $626,769,000.00
- Revenue This Year
- PTGX N/A
- BUR $32.22
- Revenue Next Year
- PTGX $47.15
- BUR $6.31
- P/E Ratio
- PTGX $62.27
- BUR $11.86
- Revenue Growth
- PTGX N/A
- BUR N/A
- 52 Week Low
- PTGX $30.67
- BUR $10.70
- 52 Week High
- PTGX $60.60
- BUR $15.73
- Technical
- Relative Strength Index (RSI)
- PTGX 58.33
- BUR 25.15
- Support Level
- PTGX $54.48
- BUR $10.70
- Resistance Level
- PTGX $57.18
- BUR $12.72
- Average True Range (ATR)
- PTGX 2.04
- BUR 0.36
- MACD
- PTGX -0.09
- BUR -0.22
- Stochastic Oscillator
- PTGX 57.13
- BUR 10.71
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About BUR Burford Capital Limited
Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Principal Finance, which allocates capital to legal finance assets from its balance sheet, primarily as capital provision assets and in limited scope through interests in private funds managed by the company; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.